Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Eupraxia Pharmaceuticals Inc. EPRX

Full chart Compare
Set alert

Price alert · EPRX

All alert types
6.81 USD -0.08 (-1.09%)

Nov 4, 2026, 3:36 PM EST

6.60 Day range 7.01
5.45 52-week range 9.10
YTD
-9.87%
1 year
+24.86%

Financial health

Altman Z-Score

35.22 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 2

Valuation

P/E -7.3×
FY 2017: -10.9×FY 2018: -3.9×FY 2019: -6.8×FY 2020: -12.1×FY 2021: -1.9×FY 2022: -4.2×FY 2023: -3.4×FY 2024: -4.2×FY 2025: -7.3×
FY 2017 5y median -4.2× FY 2025
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
P/B 3.7×
FY 2017: 8.0×FY 2018: -4.7×FY 2019: -2.8×FY 2020: -2.3×FY 2021: 2.3×FY 2022: 7.3×FY 2023: 42.7×FY 2024: 3.2×FY 2025: 3.7×
FY 2017 5y median 3.7× FY 2025
P/FCF -10.2×
FY 2017: -8.5×FY 2018: -6.1×FY 2019: -9.5×FY 2020: -120×FY 2021: -3.9×FY 2022: -5.3×FY 2023: -4.5×FY 2024: -3.6×FY 2025: -10.2×
FY 2017 5y median -4.5× FY 2025
EV/EBITDA -5.8×
FY 2017: -8.9×FY 2018: -3.8×FY 2019: -10.5×FY 2020: -30.3×FY 2021: -2.0×FY 2022: -3.6×FY 2023: -3.1×FY 2024: -3.0×FY 2025: -5.8×
FY 2017 5y median -3.1× FY 2025
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
FCF Yield -9.8%
FY 2017: -11.8%FY 2018: -16.3%FY 2019: -10.5%FY 2020: -0.8%FY 2021: -25.8%FY 2022: -19.0%FY 2023: -22.0%FY 2024: -28.0%FY 2025: -9.8%
FY 2017 5y median -22.0% FY 2025

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
ROE -47.0%
FY 2017: -73.3%FY 2018: 119.3%FY 2019: 41.7%FY 2020: 18.9%FY 2021: -120.1%FY 2022: -175.4%FY 2023: -1273.4%FY 2024: -76.3%FY 2025: -47.0%
FY 2017 5y median -120.1% FY 2025
ROIC -47.7%
FY 2017: -94.6%FY 2018: 157.4%FY 2019: 119.8%FY 2020: 29.0%FY 2021: -63.1%FY 2022: -80.4%FY 2023: -245.5%FY 2024: -84.6%FY 2025: -47.7%
FY 2017 5y median -80.4% FY 2025
ROA -44.8%
FY 2017: -73.9%FY 2018: -453.4%FY 2019: -224.4%FY 2020: -275.6%FY 2021: -76.7%FY 2022: -71.4%FY 2023: -139.3%FY 2024: -73.0%FY 2025: -44.8%
FY 2017 5y median -73.0% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 FY 2025
Operating Income -42.3%
FY 2017: 0.0%FY 2018: -144.1%FY 2019: 43.2%FY 2020: 63.7%FY 2021: -642.6%FY 2022: 4.1%FY 2023: -19.0%FY 2024: -28.8%FY 2025: -42.3%
FY 2017 FY 2025
EPS (diluted) -35.5%
FY 2017: 0.0%FY 2018: -202.9%FY 2019: 45.6%FY 2020: 44.6%FY 2021: -522.6%FY 2022: 50.3%FY 2023: 8.3%FY 2024: 13.6%FY 2025: -35.5%
FY 2017 FY 2025
Free Cash Flow 1.6%
FY 2017: 0.0%FY 2018: -50.8%FY 2019: 38.8%FY 2020: 92.2%FY 2021: -2851.3%FY 2022: -22.8%FY 2023: -7.2%FY 2024: -92.0%FY 2025: 1.6%
FY 2017 FY 2025

Financial Health

Current Ratio 15.1×
FY 2017: 7.5×FY 2018: 0.2×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 13.5×FY 2022: 6.1×FY 2023: 1.0×FY 2024: 11.1×FY 2025: 15.1×
FY 2017 5y median 11.1× FY 2025
Quick Ratio 15.1×
FY 2017: 7.5×FY 2018: 0.2×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 13.5×FY 2022: 6.1×FY 2023: 1.0×FY 2024: 11.1×FY 2025: 15.1×
FY 2017 5y median 11.1× FY 2025
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: -0.3×FY 2019: -0.7×FY 2020: -0.6×FY 2021: 0.5×FY 2022: 1.2×FY 2023: 4.7×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.5× FY 2025
Net Debt / EBITDA 2.1×
FY 2017: 0.8×FY 2018: -0.2×FY 2019: -1.9×FY 2020: -6.3×FY 2021: 0.6×FY 2022: 0.7×FY 2023: 0.3×FY 2024: 1.3×FY 2025: 2.1×
FY 2017 5y median 0.7× FY 2025
Interest Coverage 0.0×
FY 2017: -93.3×FY 2018: -84.6×FY 2019: -4.7×FY 2020: -1.3×FY 2021: -15.8×FY 2022: -17.9×FY 2023: -23.8×FY 2024: -44.7×FY 2025: 0.0×
FY 2017 5y median -17.9× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31